Pasithea Therapeutics
KTTA • NASDAQ
Pasithea Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Tiago Reis Marques, with a market cap of $17.2M.
Market Cap$17.2M
Employees8.0
CEOTiago Reis Marques
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsJun 3, 2026 · in a monthQ1 2027
Financials
Pasithea Therapeutics FAQ
Common questions about Pasithea Therapeutics
Pasithea Therapeutics is scheduled to report earnings for Q1 2027 on June 3, 2026. Analysts estimate revenue of $300.0K.
Pasithea Therapeutics has approximately 8 employees.